Semaglutide is the active ingredient in Ozempic. They are not two different drugs. Ozempic is simply one brand name that Novo Nordisk uses to sell semaglutide as a once-weekly injection. The confusion is understandable, though, because semaglutide is also sold under other brand names for different purposes, and the distinction between the molecule and the product matters more than you might expect.
Semaglutide Is the Drug, Ozempic Is the Product
Think of it like ibuprofen and Advil. Semaglutide is the pharmaceutical compound, and Ozempic is a specific branded product built around that compound. The FDA label for Ozempic states it plainly: the active ingredient is semaglutide, a human GLP-1 receptor agonist.
What semaglutide does in the body is mimic a natural gut hormone called GLP-1 that your intestines release after you eat. This triggers several effects at once. It signals your pancreas to release more insulin when blood sugar is high, tells your liver to produce less sugar, slows down how fast food leaves your stomach (which keeps you feeling full longer), and acts on appetite centers in the brain to reduce hunger. That combination of effects is why semaglutide works for both blood sugar control and weight loss.
Three Brand Names, One Molecule
Novo Nordisk sells semaglutide under three distinct brand names, each approved for different conditions and sometimes at different doses.
- Ozempic is a once-weekly injection approved for type 2 diabetes management, cardiovascular risk reduction in adults with type 2 diabetes and heart disease, and kidney protection in adults with type 2 diabetes and chronic kidney disease. Its maximum dose is 2 mg.
- Wegovy is also a once-weekly injection, but it’s approved for weight management in adults and children 12 and older, for a type of fatty liver disease called MASH, and for cardiovascular risk reduction in adults with obesity or overweight and heart disease. Its maximum dose is higher at 2.4 mg. Wegovy comes in single-use pens, while Ozempic uses a multi-use pen.
- Rybelsus is an oral tablet form of semaglutide, approved for type 2 diabetes. Because semaglutide is a protein that the stomach would normally break down, Rybelsus has strict absorption requirements: you take it on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other medications.
All three contain the same semaglutide molecule. The differences come down to the dose, the delivery method, and what the FDA has approved each product to treat. Your doctor can only prescribe each one for its approved uses, which is why Ozempic and Wegovy exist as separate products even though they contain the same drug.
What About Compounded Semaglutide?
If you’ve seen semaglutide advertised by compounding pharmacies or telehealth startups, that product is not the same as Ozempic, Wegovy, or Rybelsus. The FDA has raised specific safety concerns here. Some compounded versions use salt forms of the molecule, such as semaglutide sodium or semaglutide acetate, which the FDA considers different active ingredients from the semaglutide in approved products. The agency has stated directly that it has no evidence these salt forms share the same chemical and pharmacological properties as brand-name semaglutide, and it is not aware of any lawful basis for using them in compounding.
This matters because even small molecular changes can affect how a drug is absorbed, how long it stays active in your body, and whether it works as expected. A compounded product labeled “semaglutide” is not automatically interchangeable with Ozempic or Wegovy.
Cost of Brand-Name Semaglutide
Ozempic carries a list price of roughly $1,000 per pen regardless of the dose strength. That’s the manufacturer’s price before insurance discounts or rebates, and most people with commercial insurance pay significantly less. How much you actually owe depends on your plan’s formulary, your deductible status, and whether your insurer covers Ozempic at all. Medicaid coverage varies by state, with some states requiring no copay. Medicare Part D enrollees may qualify for extra help through the Low Income Subsidy program.
Because Ozempic and Wegovy are priced similarly and contain the same molecule, some people with obesity have sought Ozempic prescriptions off-label for weight loss when their insurance won’t cover Wegovy. This has contributed to supply shortages and is one reason the brand-name distinction between these products carries real practical weight for patients.
The Short Answer
Semaglutide and Ozempic are not two different things. Semaglutide is the drug; Ozempic is one of three FDA-approved products that deliver it. If someone mentions “semaglutide” without specifying a brand, they could be referring to Ozempic, Wegovy, Rybelsus, or even a compounded version, and those are not all interchangeable despite sharing the same core molecule.